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SUMMARY 
Through close cooperation with the Ministry of 
Health and Family Welfare (MoH&FW) of the 
People’s Republic of Bangladesh, and other 
partners, STEP UP generated strong evidence 
and cultivated ongoing collaboration that 
contributed to policy changes and programme 
expansions. These changes are increasing 
women’s access to menstrual regulation with 
medication (MRM) in Bangladesh, and include:  
 Approval of MRM services introduction in the 
national family planning program 
 Approval of MRM scale up nationwide in 
public facilities, and creation of strategic plan 
for scale up; 
 Development of national MRM service 
delivery guidelines and training curriculum; 
 MRM combination drugs locally manufactured 
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FROM EVIDENCE TO IMPACT: A look at how STEP UP 
research was used to impact policies and programmes 
The goal of family planning and reproductive health operations research is not merely to 
generate evidence but also to inform policies and programmes to solve the problems of 
women’s access to and quality of services. Yet the crucial step of ensuring the utilization 
of that evidence often receives inconsistent or inadequate attention. There is relatively 
little monitoring and reporting on whether and to what effect project results are utilized, or 
on the nature, process, and efficacy of the strategies employed to achieve this.  
The aim of this case study is to present an activity of the STEP UP research programme 
consortium that resulted in successful evidence utilization. This is to both demonstrate 
the positive impact STEP UP is having on family planning and reproductive health 
policies and programmes, as well as to document the process by which this was 
achieved so as to inform future research of successful strategies and lessons learned.  
CASE 
STUDY 
 Memorandum of Understanding signed 
with the Director General of Family 
Planning to assist in scale up MRM 
services to nearly 4,000 health facilities; 
 Development of a core group of 13 master 
trainers and trained service providers in 
MRM service provision (108 physicians 
and 126 family welfare visitors from 
Maternal and Child Welfare Centres 
(MCWCs); and 
 Successful service expansion to 70 urban 
MCWCs and in all urban health and family 


















Despite the availability of effective modern contraceptive 
methods in Bangladesh, the number of unsafe abortions 
rises each year, increasing risk of maternal morbidity and 
mortality.1,2 
 
Menstrual regulation (MR) is an interim method of safely 
establishing non-pregnancy after a missed period, 
regardless of whether conception has occurred or not, and 
is usually done without a pregnancy test. Its availability 
helps to decrease the number of women who have unsafe 
abortions – and consequently, decreases maternal 
mortality and morbidity.3 Indeed, effective implementation 
of the MR policy in Bangladesh has contributed to a 
reduction in maternal mortality from 24% to 11% between 
1976 and 2005.4 In Bangladesh, MR is typically conducted 
using manual vacuum aspiration (MVA), a surgical 
method.  
 
However, MR using MVA carries risks of social stigma and 
significant post-MVA complications if service quality is 
poor or unhygienic.  Despite the fact that MR using MVA is 
a safe and legal service that is widely available in most 
public health facilities, approximately 650,000 women 
each year are unable to access this service – prompting 
them to resort to more discreet but illegal induced 
abortions, most of which are unsafe.2 Addressing the 
barriers that prevent women from using MR services 
would reduce illegal and unsafe abortion and the 
associated mortality and morbidity. 
 
Menstrual regulation with medication (MRM) is an 
important tool for achieving non-pregnancy after a missed 
period. MRM is a safe, WHO-approved, non-invasive 
alternative to MVA. The most effective drug formulation for 
MRM is a Misoprostol-Mifepristone combination.  
 
However, MRM is not yet widely available in Bangladesh. 
By increasing access to this simple and safe MR option, 
women’s morbidity due to MR and unsafe abortion in 
Bangladesh could be greatly decreased. 
THE PROJECTS 
STEP UP partners in Bangladesh have worked to 
understand the barriers to MRM access and identify 
possible solutions. Our projects have explored (1) why 
women undergo induced and/or unsafe abortions and 
what barriers they face to accessing legal MR, and (2) the 
feasibility of introducing MRM in Bangladesh as a solution, 
and the acceptability of providing MRM using the 
Mifepristone-Misoprostol drug combination in urban and 
rural public health facilities.  
 
Understanding unintended pregnancy in Bangladesh: 
Country Profile: STEP UP conducted an extensive review 
and critical analysis of literature on existing MR and 
abortion policies and programmes in Bangladesh, seeking 
to understand why and how women undergo unsafe 
abortions and why they do not obtain MR.  Relevant local 
research-based organisations were consulted, pertinent 
documents were collected, and PubMed/MEDLINE, 
HINARI, JSTOR and Google Scholar were searched.5  
 
icddr,b has also developed a stakeholder analysis which 
provides information about factors that contribute to 
pregnancy termination in Bangladesh and about a range 
factors that contributed to the approval process of MRM in 
Bangladesh.6  
 
Assessing the feasibility and acceptability of 
introducing MRM in Bangladesh: In collaboration with 
the Directorate General of Family Planning (DGFP) and 
the World Health Organisation, STEP UP partners tested 
the feasibility and acceptability of introducing MRM using 
the Mifepristone-Misoprostol drug combination in urban 
and rural public health facilities. An 18-month operations 
research study was conducted from January 2012 to June 
2013. Health facilities were selected with high numbers of 
MR clients and available trained service providers.1 All 
women who visited the 13 health facilities for MR services 
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from October 2012 -- May 2013 were invited to 
participate in the study. All women were counseled by 
trained service providers about the advantages, 
disadvantages, and side effects of MR and given a 
choice between MVA and MRM to regulate 
menstruation.1  
 
KEY STUDY FINDINGS  
Understanding barriers to women’s 
access to MR and recourse to unsafe 
abortion  
 MR services (MVA) are available at the majority of 
public facilities at district, sub-district, and union 
levels, as well as at some private and NGO facilities. 
 Women are deterred from seeking MR services due 
to distance to the facility, unofficial fees for the 
service, lack of privacy and risk of stigma, and 
negative provider attitudes.5  
 As of 2011, 10,600 doctors and 7,200 paramedics 
(mainly family welfare visitors) had been trained to 
provide MR services through MVA, yet a minority of 
the providers trained to provide MR actually do so.5, 7  
 26% of women seeking MR are rejected by 
providers. Most providers indicated that the women 
had exceeded the then-legal time limit of 10 weeks 
since their last menstrual period, but many rejected 
women for discriminatory reasons.  
 Many of these providers refuse to provide MR 
services because of personal feelings, including: if 
the woman is childless (20%), if they felt she was too 
young (12%) if she is unmarried, widowed, or 
divorced (8%) or if she lacks consent from her 
husband or guardian, although this is only legally 
required for minors or the mentally handicapped 
(7%).5, 8 
 Few women (11%) obtain MR free of charge, despite 
the fact that public-sector MR is supposed to be 
available at no cost.5 
 Adolescent girls – especially those who are 
unmarried – are at higher risk of unsafe abortion. 
One study indicated that the risk of abortion for 
unmarried adolescents was 35 times greater than 
among those who are married. This may be due to 
high stigma against unmarried pregnancy, or to 
inadequate adolescent awareness of reproductive 
health resources including MR. Sex workers are also 
at higher risk of unsafe abortion.5, 9  
Testing the feasibility and 
acceptability of introducing MRM into 
rural and urban public health facilities  
 Nearly all providers identified the last menstrual 
period and 70% took a menstrual history. The overall 
quality of services provided at these health facilities 
was high. 
 One in five clients experienced a side effect 
(commonly nausea) after taking Mifepristone (first 
dose), although less than half of these women 
required medication or further treatment for the side 
effects. 
 Almost two-thirds of women preferred MRM to MVA. 
 Nearly all women who chose MRM (97%) reported 
that they would suggest MRM to their friends and 
relatives; 95% would refer a friend to the same 
facility. Virtually all women receiving MRM reported 
being satisfied/very satisfied with the quality of care.  
 The vast majority (92%) of women returned to the 
facility after 14 days for the examination to confirm 
procedure completion.1 
 
The study suggested that it is safe and feasible to 
introduce MRM in Bangladesh in rural and urban public 
health facilities.1  
 
MAKING AN IMPACT 
Influencing policy and programme 
improvements 
The legalization, introduction, and expansion of MRM in 
Bangladesh has been made possible by the collaborative 
efforts of many local, national, and international 
stakeholders, of which STEP UP is one. Specific to our 
efforts, focused stakeholder engagement and utilization of 
study findings contributes to several impacts: 
 
MRM approved for introduction and scale-up in 
national family planning programme  
Findings of the study were presented at the 61st National 
Technical Committee (NTC) meeting and it was 
subsequently approved by the NTC and Drug 
Administration that the combination MRM drug 
(Mifepristone-Misoprostol) be introduced into the national 
family planning programme. It was approved in this 
meeting that initial introduction be initiated by phases, 
starting in urban areas.10 It was also requested by DGFP 
that STEP UP provide technical assistance during the 
scale up phases to ensure availability of MRM services 






























































Memorandum of Understanding signed to scale up 
MRM nationwide after initial introduction 
Based on discussions during the NTC meeting, a 
tripartite Memorandum of Understanding (MOU) was 
signed between the Directorate General of Family 
Planning (DGFP) under the MoH&FW, Bangladesh, and 
STEP UP partners (Population Council and MSI) to scale 
up MRM throughout Bangladesh.  
 
In this MOU, STEP UP agreed to provide technical 
assistance for the scaling up of MRM services to all 
(nearly 4,000) Maternal and Child Welfare Centres 
(MCWCs) and Union Health and Family Welfare Centres 
(UH&FWCs), to support the implementation process, and 
to assist the DGFP to ensure the availability of the 
required commodities. Subsequently, a project advisory 
committee (PAC) and technical group were formed to 
support STEP UP in carrying out this agreement.  
 
National service delivery guidelines and training 
curriculum developed 
As agreed in the MOU, the DGFP formed a technical 
committee (including the DGFP, DGHS, Obstetrical and 
Gynecological Society of Bangladesh, RH STEP, Marie 
Stopes Bangladesh, Ipas, and BAPSA) to develop 
national service delivery guideline for MRM. STEP UP 
worked within the technical committee as well as with 
local experts to develop the service delivery guidelines 
and a training curriculum for MRM service providers.  
 
These guidelines and curricula were finalized and 
approved by the PAC, translated into Bengali, and are 
being used to provide consistent information to different 
cadres of service providers.  
Strategic plan for MRM service scale-up created  
STEP UP assisted the DGFP in the development of a 
strategic plan for the vertical expansion of MRM services 
in the nearly 4,000 MCWCs and UH&FWCs. The DGFP 
will carry out this expansion starting with the incorporation 
of MRM services into their 5th HNP sector programme. 
The scale up programme has been completed in all 70 
MCWCs and two districts of Khulna Division. 
 
Master Trainers identified and trained 
One of the major objectives of MRM scale-up activities 
was to develop a national pool of Master Trainers (MTs) 
on MRM who can be utilized during the nationwide 
services expansion. The MTs were selected by the PAC 
and were from DGFP, DGHS, OGSB, MSB and 
Population Council. All MTs were physicians and had 
previous extensive experience on training on MR service 
provision. A total of 13 MTs were trained. 
 
Urban service providers trained in MRM provision 
While testing the feasibility of providing MRM services to 
women in public health facilities, STEP UP trained all 
eligible providers in 70 urban Maternal and Child Welfare 
Centres in safe provision of MRM services. A total of 108 
physicians and 126 FWVs were trained. 
 
MRM combination drugs supplied to 70 MCWCs 
With support from WHO, Marie Stopes supplied MRM 
combinations drugs to all 70 MCWCs. A total of 12,000 
combinations drugs were supplied, a one-year supply. 
 
MRM training expanded into rural areas  
Further, STEP UP organized an orientation and training 
programmes in Khulna Division to underpin the DGFP’s 
scale-up of services according to the strategic plan. Sixty 
(60) programme managers of 10 districts of Khulna 
Division received training in MRM service provision and 
28 medical officers for maternal and child health and 
family planning (MOMCH) were trained as trainers to 
enable subsequent provider training (which was 
supported by two Master Trainers from the Ministry of 
Health and Family Welfare).  
 
Training on MRM was further expanded to Family Welfare 
Visitors (FWVs) and female Sub Assistant Community 
Medical Officers (SACMOs) of Khulna and Jessore 
District. Training was conducted by a government Master 
Trainer and two medical officers (MOMCH) who had 
participated in the Training of Trainers programme. A total 
of 73 FWVs from UH&FWCs and 6 female SACMOs in 
both districts.   
Dr. Farid Uddin Ahmed, Assistant Director, MCH-Service 







MRM combination drugs locally manufactured  
for first time 
After the approval of MRM drugs by the Directorate 
general of Drug Administration (DGDA), several local 
pharmaceutical companies in Bangladesh started 
manufacturing the Misoprostol/Mifepristone combination 
drug. Now, it is manufactured by several companies.  
 
This change stands to promote women’s access to MRM 
commodities by making drugs more readily available to 
local providers, reducing stock outs, and improving the 
supply chain. 
  
Who will benefit? 
 Women in need of safe, accessible MRM 
services: Having access to quality MRM services 
may help women in Bangladesh to avoid resorting to 
invasive procedures like MVA or unsafe methods of 
pregnancy terminations. This stands to help prevent 
women’s illness, injury, and even death. Further, 
before the addition of MRM to the method mix, only 
MVA was available. Adding more options gives 
women the freedom to choose the method that is 
right for them.    
 Public health facilities: If women increasingly use 
MRM instead of MVA or unsafe methods of 
pregnancy termination, fewer women may need to 
be treated for complications from these procedures, 
thus reducing the burden placed upon clinics that 
may be overworked and underfunded. Furthermore, 
by increasing the number of providers who can 
provide MRM, improving their training, and improving 
the availability of supplies, public health facilities 
may provide better services more reliably.  
HOW WAS IMPACT ACHIEVED? 
SOME KEY LESSONS LEARNED 
Close collaboration with government 
and professional societies  
Critical to STEP UP’s impact in Bangladesh has been a 
close and ongoing collaboration with both government 
ministries as well as with professional organisations.  
Importantly, the project team sought to ensure these 
individual relationships remained positive, cooperative, 
reliable, and were productive rather than obstructive. 
STEP UP activities also have had the support and 
participation from not only the broad membership of these 
groups but from individuals in leadership roles.  
 
The Ministry of Health and Family Welfare, specifically 
the Dr. Nur Hossain Talukder (Director General, DGFP), 
and Dr. Mohammed Sharif (Director, MCH Services Unit, 
DGFP) took an active role in organizing and 
implementing the MRM training programme. This 
included the formation of a technical working group, 
hosting the training programme and providing resource 
persons, and the DGFP inaugurating and closing each 
training session.  
 
STEP UP also collaborated closely with the Obstetrical 
and Gynaecological Society of Bangladesh (OGSB). The 
OGSB played an important role in developing the service 
delivery guidelines, reviewing information education and 
communication (IEC) materials, and providing training to 
the service providers. Former OGSB President Dr. 
Rashwan Ara and Secretary General Dr. Farhana Dewan 
actively participated in developing the service delivery 
guideline, selection of Master Trainers and providing 
training to Master Trainers.  Furthermore, former 
president of the OGSB Dr. Latifa Samsuddin attended 
each training session.  
 
When the STEP UP team proposed policy adoption 
before the NTC, it was done in collaboration with local 
policy makers and programme managers. This dynamic 
of partnership, inclusivity, and responsiveness to 
identified local needs was key in successful adoption of 
policies. 
 






























































Strong project partnership featuring a 
range of expertise and resources   
Marie Stopes Bangladesh (MSB), the Population Council, 
and OGSB brought unique strengths to a productive 
partnership, which was significant in helping to promote 
MRM policy adoption. That MSB is a service delivery 
agency was valuable in helping to make the study’s 
recommendations feasible and acceptable to the 
MOHFW. MSB was able to facilitate clinical training 
sessions, procure and supply the necessary MRM drugs 
to the DGFP, and serve as referral centres to provide 
backup support to referred MRM clients of government 
facilities for management of side effects or complications.   
 
Population Council research, in addition to data gathered 
by icddr,b, contributed strong evidence that helped to 
underpin the merit of the policy and programme changes 
made to support MRM service provision. The Council 
also helped to lead in the design, organisation, and 
implementation of the overall MRM scale up activities, 
logistical support and knowledge management, including 
the development of two databases of service providers 
posted to MCWCs, aiding in effective communication for 
selection of participants in MRM training.  
 
Sound evidence that reflected a 
receptive public, engaged service 
providers, and supportive policy 
environment 
Studies carried out by STEP UP and others generated 
strong evidence indicating that women vastly preferred 
MRM over MVA – especially the ease, safety, and 
privacy of MRM.1 Furthermore, although some service 
providers decline to provide MRM, the majority indicated 
that being able to offer MRM would enable them to better 
serve women for whom MVA was an inappropriate 
option, or when MVA supplies were limited.11 They 
expressed excitement about MRM as a welcome, safer, 
in-demand service that they wanted to be able to offer 
women.12 Providers and clients alike perceived MRM as 
a non-invasive, more suitable, technologically-simple, 
and easy-to-use alternative method to MVA.6  
 
In addition, linking project activities to evidence and 
recommendations from WHO – as a respected and 
globally-acknowledged authority on the issue – helped to 
affirm STEP UP’s findings and recommendations as 
credible among providers and policymakers.  
 
The DGFP was keen to introduce an alternative to MVA, 
reflected in their commitment to support STEP UP 
research and formalizing an MOU with Population 
Council and MSB. Their support was continually borne 
out throughout STEP UP’s research and training 
processes; the MCH-Services unit has taken active roles 
in organizing and implementing the MRM training 
program, has formed a project advisory committee to 
guide, monitor and supervise the programme activities, 
has formed a technical working group to guide 
development of guidelines and IEC materials, and hosts 
and staffs the MRM training programmes. 
 
DISCUSSION 
Achieving impact through research uptake hinged on 
several strategies that enabled the project partners to 
identify and pursue the relevant local mechanisms for 
policy adoption. These strategies included: 
 Close collaboration with government and 
professional societies  
 Strong project partnership featuring a range of 
experience and resources 
 Strong evidence generated that reflected a receptive 
public, open-minded service providers, and 
supportive policy environment 
It was important for STEP UP to underpin the above 
efforts by focusing on the dynamics with which they 
engaged policymakers. By cultivating sensitive 
interpersonal dynamics that paid attention to policy maker 
priorities, concerns, obstacles, and opportunities, STEP 
UP partners were able to build trust, strategically frame 
recommendations and their intended outcomes in positive 
terms that focused on shared goals, prioritize 
participation of policymakers and managers in evidence 
gathering, and generally ensure that personal 
relationships with stakeholders and policymakers 
remained pleasant, cooperative, and reliable. 
 
Professor Dr. Latifa Samsuddin, immediate past President, 




© 2017 POPULATION COUNCIL. 
CONCLUSION 
Although nearly all contraceptive methods are approved 
and available in Bangladesh, each year unintended 
pregnancies compel women to resort to unsafe methods 
of pregnancy termination. MR is a procedure that uses 
MVA to safely establish nonpregnancy after a missed 
period, but is not suitable for all women. MVA can be 
unsafe when the quality of service is poor, administered 
by inadequately trained service providers in unhygienic 
settings. Menstrual Regulation with Medication (MRM) is a 
safe, effective, low-cost alternative to MVA that is vastly 
preferred by both women and providers.  
 
The most effective drug formulation for MRM is a 
Misoprostol-Mifepristone drug combination. Previous to 
STEP UP’s activities, the drug Misoprostol had been 
available in Bangladesh for several non-MRM uses. 
However, Mifepristone was not approved as it was 
branded as abortifacient. Through collaborative advocacy 
efforts and strong evidence, the combined drug was 
approved for use in MRM services, is being locally 
manufactured, and is being used in nationwide scale up of 
MRM service delivery.  
 
Now that it is clear that MRM is acceptable and effective 
in Bangladesh, has been legalized and folded into the 
national FP program, and is being scaled up nationwide, 
ongoing observation and studies are still needed. It is 
important to understand whether the efficacy and 
acceptability of MRM remains the case when services are 
delivered at scale on a national level. Follow-up studies 
should gather data on who is seeking services, whether 
they are doing it correctly, how frequently they are doing 
it, what complications they face (if any), are whether they 
are getting enough attention if there is a complication.  
 
Additionally, although the government is coordinating 
nationwide scale up in public facilities, we must consider 
the role that the private sector plays in women’s access to 
MRM, especially considering that the government has 
little control over the drugs sold in pharmacies. Although 
the drugs are not approved for sale over-the-counter, 
pharmaceutical companies are aggressively marketing 
Misoprostol to pharmacists, despite the fact that they may 
not be properly trained and the fact that Misoprostol is 
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